Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6T | 2.1T | 1.9T | 1.6T |
Cost of revenue | 1.5T | 2.0T | 1.7T | 1.5T |
Gross profit | 100.5B | 131.0B | 114.7B | 99.5B |
Operating expense | ||||
Research & development | 26.6B | 34.1B | 29.2B | 29.2B |
Selling general and admin | 27.4B | 32.4B | 30.8B | 25.7B |
Other operating expenses | — | — | — | — |
Operating income | 46.5B | 64.5B | 54.8B | 44.6B |
Non operating interest income | ||||
Income | 8.1B | 9.6B | 8.8B | 11.8B |
Expense | 7.5B | 8.1B | 8.8B | 9.3B |
Other income expense | — | — | — | — |
Pretax income | 59.1B | 63.3B | 67.7B | 48.4B |
Tax provision | 13.3B | 10.8B | 12.3B | 9.5B |
Net income | 45.8B | 52.5B | 55.3B | 38.9B |
Basic EPS | 6.1 | — | 7.1 | 5.1 |
Diluted EPS | 6.0 | — | 7.0 | 5 |
Basic average shares | 6.9B | — | 6.9B | 6.9B |
Diluted average shares | 7.1B | — | 7.0B | 7.0B |
EBITDA | 90.2B | 97.9B | 98.0B | 77.2B |
Net income from continuing op. | 59.1B | 63.3B | 67.7B | 48.4B |
Minority interests | -3.7B | -6.2B | -6.0B | -3.9B |
Preferred stock dividends | 0 | 0 | 0 | 0 |